DIASTOLIC DYSFUNCTION IN PATIENTS WITH RENAL-FAILURE

被引:0
|
作者
MANDELBAUM, A
ZEIER, M
RITZ, E
机构
关键词
LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; RENAL FAILURE; UREMIC CARDIOMYOPATHY; LEFT VENTRICULAR HYPERTROPHY; HEMODIALYSIS-ASSOCIATED HYPOTENSION;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Left ventricular hypertrophy of the concentric or asymmetric-septal type is the most common pathological finding in the heart of dialysis patients, while heart size and left ventricular systolic function are usually within the normal range. A reduced left ventricular compliance (or increased myocardial stiffness) is frequently present, leading to compromised diastolic filling. Left ventricular hypertrophy and diffuse interstitial fibrosis of the myocardium have been demonstrated both in uremic animals and in dialysis patients. They are thought to be responsible for diastolic dysfunction. Clinical sequelae of the compromised diastolic filling consist of a propensity towards hemodynamic instability during hemodialysis on the one hand. Ultrafiltration causes a rapid fall of cardiac filling pressure that is necessary for the maintenance of an adequate cardiac output. On the other hand, affected patients are at an increased risk of developping pulmonary edema with relatively small increments of intravascular volume. During hemodialysis the lowest possible ultrafiltration rates should be sought. Therapeutic alternatives such as peritoneal dialysis or hemofiltration, where changes of extracellular volume and/or of the electrolyte composition occur less rapidly, should be considered in such patients.
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [41] ADMINISTRATION OF CEPHRADINE TO PATIENTS IN RENAL-FAILURE
    SOLOMON, AE
    BRIGGS, JD
    MCGEACHY, R
    SLEIGH, JD
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (05) : 443 - 448
  • [42] KETANSERIN PHARMACOKINETICS IN PATIENTS WITH RENAL-FAILURE
    BARENDREGT, JNM
    VANPEER, A
    VANDERHOEVEN, JG
    VANOENE, JC
    TJANDRA, YI
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (06) : 715 - 723
  • [43] MANNITOL INTOXICATION IN PATIENTS WITH RENAL-FAILURE
    BORGES, HF
    HOCKS, J
    KJELLSTRAND, CM
    ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (01) : 63 - 66
  • [44] ISONIAZID DOSAGE IN PATIENTS WITH RENAL-FAILURE
    BOWERSOX, DW
    WINTERBAUER, RH
    STEWART, GL
    ORME, B
    BARRON, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (02): : 84 - 87
  • [45] EFFICIENCY OF PATIENTS WITH CHRONIC RENAL-FAILURE
    SCHAUMANN, HJ
    HUBER, W
    KEMPMANN, G
    NEUSS, H
    STEGARU, B
    SCHEUERLEN, H
    MEDIZINISCHE KLINIK, 1977, 72 (36) : 1443 - 1446
  • [46] FAIR DEAL FOR PATIENTS WITH RENAL-FAILURE
    不详
    BRITISH MEDICAL JOURNAL, 1975, 1 (5952): : 232 - 233
  • [47] AMINOACIDURIA IN PATIENTS WITH CHRONIC RENAL-FAILURE
    NADVORNIKOVA, H
    SCHUCK, O
    TEPLAN, V
    TOMKOVA, D
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1979, 9 (02) : 25 - 25
  • [48] SKELETAL PATHOLOGY IN PATIENTS WITH RENAL-FAILURE
    INGHAM, JP
    STEWART, JH
    POSEN, S
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1972, 2 (04): : 428 - &
  • [49] PHARMACOKINETICS OF NAFCILLIN IN PATIENTS WITH RENAL-FAILURE
    DIAZ, CR
    KANE, JG
    PARKER, RH
    PELSOR, FR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (01) : 98 - 101
  • [50] FLEROXACIN METABOLISM IN PATIENTS WITH RENAL-FAILURE
    STUCK, AE
    WEIDEKAMM, E
    HEIZMANN, P
    FREY, FJ
    KIDNEY INTERNATIONAL, 1989, 36 (02) : 318 - 318